P27 BRCA/HRD genetic status does not increase toxicity to PARP inhibitors or next-line cytotoxic chemotherapy in women with epithelial ovarian cancer

Authors :: Alyssa Wield
Alicia Liu
Christine McGough
Jessica Berger
Michelle Boisen
Lan Coffman
Robert Edwards
Madeleine Courtney-Brooks
Jamie Lesnock
Alexander Olawaiye
Paniti Sukumvanich
Ronald Buckanovich
Haider Mahdi
Sarah Taylor
Source :: Gynecologic Oncology. 165:S19-S20
Publication Year :: 2022
Publisher :: Elsevier BV, 2022.

Tools